UK Industry Backs New Turkey Vaccine Trial in Bird Flu Fight

The UK poultry industry has welcomed a landmark trial of new vaccines against highly pathogenic avian influenza (HPAI) in turkeys, marking a pivotal step in tackling bird flu.

David Corredor

The UK poultry industry has welcomed a landmark trial of new vaccines against highly pathogenic avian influenza (HPAI) in turkeys, marking a pivotal step in tackling bird flu. The trial, launched in March 2026, focuses exclusively on turkeys due to their high susceptibility to the disease and aims to provide science-led solutions to protect flocks and sustain trade.

Background: Bird Flu Challenges in the UK

• Avian influenza (HPAI) has caused severe disruption to both commercial and backyard flocks in recent years.
• Turkeys are particularly vulnerable, with past outbreaks leading to rapid onset of clinical signs and high mortality.
• The British Poultry Council emphasized the need for sustainable, science-led solutions to reduce the strain on producers.

Details of the New Vaccine Trial

• Launch date: Early March 2026.
• Location: England, under the supervision of the Department for Environment, Food & Rural Affairs (DEFRA) and the Animal and Plant Health Agency.
• Focus: Exclusively on turkeys, testing vaccine efficacy in real-world farm conditions.
• Goals:
  • Assess how well vaccines protect turkeys against HPAI.
  • Explore surveillance strategies to maintain international trade.
  • Provide insights into long-term disease management.

Industry Reaction

• Positive reception: UK poultry producers view the trial as a turning point in the fight against bird flu.
• Trade implications: Successful vaccination could help the UK retain export markets by showing effective disease control.
• Scientific importance: The trial is expected to generate valuable data on vaccine performance and monitoring systems.

Why Turkeys?

• Turkeys are more susceptible to HPAI compared to chickens or ducks.
• Outbreaks in turkeys often result in high mortality rates, making them a priority species for vaccine testing.
• Protecting turkeys is critical for both commercial production and food security.

Broader Context

• Across Europe, avian influenza cases have recently declined after a winter peak, but the overall number of outbreaks remains higher than in previous years.
• The UK trial aligns with broader European efforts to strengthen biosecurity and disease prevention.

Key Takeaways

• First targeted turkey vaccine trial in the UK against bird flu.
• Aims to balance animal health, trade sustainability, and biosecurity.
• Seen as a critical step forward by industry leaders and government agencies.